Worldwide Healthcare (LON:WWH) Stock Crosses Below 200-Day Moving Average – Should You Sell?

Worldwide Healthcare (LON:WWH)’s share price passed below its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of GBX 350.44 ($4.41) and traded as low as GBX 318 ($4.00). Worldwide Healthcare shares last traded at GBX 321.37 ($4.04), with a volume of 2,423,619 shares.

Worldwide Healthcare Trading Down 2.2 %

The business’s fifty day moving average price is GBX 335.61 and its 200 day moving average price is GBX 350.44. The company has a quick ratio of 0.43, a current ratio of 0.29 and a debt-to-equity ratio of 2.60. The firm has a market capitalization of £1.70 billion, a PE ratio of -2,102.78 and a beta of 0.29.

Worldwide Healthcare Cuts Dividend

The firm also recently disclosed a dividend, which will be paid on Thursday, January 9th. Stockholders of record on Thursday, November 28th will be issued a dividend of GBX 0.70 ($0.01) per share. This represents a dividend yield of 0.21%. The ex-dividend date of this dividend is Thursday, November 28th. Worldwide Healthcare’s dividend payout ratio (DPR) is -2,000.00%.

Insider Activity at Worldwide Healthcare

In related news, insider Sian Hansen purchased 3,017 shares of the firm’s stock in a transaction on Wednesday, December 11th. The shares were bought at an average price of GBX 330 ($4.15) per share, for a total transaction of £9,956.10 ($12,517.10). Also, insider William Hemmings acquired 7,250 shares of the company’s stock in a transaction dated Wednesday, October 2nd. The shares were purchased at an average price of GBX 345 ($4.34) per share, with a total value of £25,012.50 ($31,446.44). Insiders own 0.41% of the company’s stock.

About Worldwide Healthcare

Worldwide Healthcare Trust PLC is a closed ended equity mutual fund launched by Frostrow Capital LLP. The fund is managed by OrbiMed Capital LLC. It invests in public equity markets across the globe. The fund seeks to invest in stocks of companies operating in the healthcare sector, with an emphasis on pharmaceutical and biotechnology companies.